Search
Main Menu
Main Content
Fermer
Choose language
FR
EN
Accessibility
Change contrast :
Standards
Reinforced
icone
HAS profile
Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest
International relations and projects
Publications
English content
Medicines
Opinions on medical devices
INAHTA briefs
French website
Chercher
Recherche
icone plus
English content
Les recommandations et guides
Les médicaments
Les actes professionnels
Les dispositifs médicaux
Les médecins accrédités
Les articles d'information
Les établissements de santé
Chercher
My account
My account
Email alert Subscription
Newsletter Subscription
My search
Refresh
Please fill in your email address to retrieve your email alerts subscriptions.
New subscription
Please fill in your email address to retrieve your newsletter subscriptions.
You do not have a saved search
Mon Compte
Sélection
No element in selection
Favoris
Sélection
Établissements de santé
Contact
Abonnez-vous aux actualités
7 results
Active substance : amitriptyline
OK
Chercher
Filter
Topic
Diseases and conditions
(5)
Plus ...
Mental disorders and behavioural conditions
(2)
Plus ...
Substance-related disorders
(1)
Eating and sleep disorders
(1)
Infectious diseases
(2)
Plus ...
Virus diseases
(2)
Sexually transmitted diseases
(1)
Nervous system diseases
(1)
Plus ...
Central nervous system diseases
(1)
Endocrine system and metabolic diseases
(1)
Plus ...
Obesity
(1)
Pain - Inflammation
(1)
Diagnostic and therapeutic techniques
(4)
Plus ...
Drug therapy
(2)
Nutrition, dietetics
(1)
Alternative medicine
(1)
Vaccine
(1)
Diagnostic techniques and procedures
(1)
Plus ...
Biology (laboratory tests)
(1)
Population groups
(2)
Plus ...
Paediatrics
(1)
Geriatrics
(1)
Economics and public health
(1)
Plus ...
Organisation of care
(1)
Content type
Practice Guidelines and Other Guides
(5)
Plus ...
Practice guidelines
(3)
Chronic disease guide
(1)
Public Health guideline
(1)
Drugs, devices and medical acts
(2)
Plus ...
Health technology assessment
(2)
Date
This year
(2)
Manufacturer
inconnu
(1)
industriels
(2)
Language
Français
(7)
Active substance
acarbose
(1)
aciclovir
(2)
acide folique
(1)
adalimumab
(1)
alcool
(4)
alemtuzumab
(1)
aluminium
(2)
amitriptyline
(7)
amoxicilline
(1)
argent
(1)
arginine
(1)
aspirine
(1)
azathioprine
(1)
basiliximab
(1)
biotine
(2)
cabergoline
(1)
chlorpromazine
(1)
citalopram
(1)
clozapine
(1)
colchicine
(1)
cuivre
(2)
cyclophosphamide
(2)
digoxine
(1)
dimercaprol
(1)
escitalopram
(1)
famciclovir
(2)
fentanyl
(1)
fer
(2)
fluconazole
(2)
gabapentine
(3)
glucosamine
(1)
glutamine
(1)
hydromorphone
(1)
infliximab
(1)
influenzinum
(1)
itraconazole
(1)
lamotrigine
(1)
lithium
(4)
lysine
(1)
mirtazapine
(1)
morphine
(2)
nadolol
(1)
naratriptan
(1)
nicotine
(1)
orlistat
(1)
ornithine
(1)
oxycodone
(1)
phosphate
(1)
phosphore
(1)
piroxicam
(1)
potassium
(4)
prednisolone
(1)
prednisone
(1)
proline
(1)
propranolol
(1)
pyridoxine
(2)
quinidine
(1)
sirolimus
(1)
sodium
(4)
spironolactone
(1)
succimer
(1)
sufentanil
(1)
sulfasalazine
(1)
sulfate de zinc
(1)
sumatriptan
(1)
thiamine
(2)
tibolone
(1)
topiramate
(2)
tryptophane
(1)
valaciclovir
(2)
valproate de sodium
(1)
venlafaxine
(2)
zinc
(4)
zolmitriptan
(1)
zonisamide
(1)
More filter
Save your search
Search Export
Practice guidelines and other guides
- 5 results
Shingles vaccination recommendations and the role of the Shingrix vaccine
Public Health guideline
- Posted on 7/3/2024
Download
abstract
Add to
my selection
Care pathway guide: overweight and obesity in adults
Chronic disease guide
- Posted on 28/2/2024
Download
guide
Add to
my selection
Bulimia nervosa and binge eating disorder
Practice guidelines
- Posted on 12/9/2019
Download
abstract
Add to
my selection
See 5 result in Practice Guidelines and Other Guides
Drugs, devices and medical acts
- 2 results
Assesment of homeopathic medicines
Health technology assessment
- Posted on 7/9/2019 - Mis à jour le 4/11/2019
Download
document
Add to
my selection
Evaluation of the gene amplification of Herpesviridae (herpes simplex and varicella-zoster virus) with mucocutaneous and ocular manifestations - INAHTA Brief
Health technology assessment
- Posted on 29/1/2016
Download
document
Add to
my selection
Français
English
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
XrRcsGmf5KJpysw3